Viewing Study NCT00325351


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-07-11 @ 10:26 PM
Study NCT ID: NCT00325351
Status: COMPLETED
Last Update Posted: 2021-04-08
First Post: 2006-05-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian cancer View
None Ovarian neoplasms, epithelium View